Wang Y - Search Results

1

The novel BET-CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild-type prostate cancer.

Yan Y, Ma J, Wang D, Lin D, Pang X, Wang S, Zhao Y, Shi L, Xue H, Pan Y, Zhang J, Wahlestedt C, Giles FJ, Chen Y, Gleave ME, Collins CC, Ye D, Wang Y, Huang H. Yan Y, et al. Among authors: wang y, wang d, wang s. EMBO Mol Med. 2019 Nov 7;11(11):e10659. doi: 10.15252/emmm.201910659. Epub 2019 Sep 26. EMBO Mol Med. 2019. PMID: 31559706 Free PMC article.

2

Development and characterization of efficient xenograft models for benign and malignant human prostate tissue.

Wang Y, Revelo MP, Sudilovsky D, Cao M, Chen WG, Goetz L, Xue H, Sadar M, Shappell SB, Cunha GR, Hayward SW. Wang Y, et al. Prostate. 2005 Jul 1;64(2):149-59. doi: 10.1002/pros.20225. Prostate. 2005. PMID: 15678503

3

An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line.

Wang Y, Xue H, Cutz JC, Bayani J, Mawji NR, Chen WG, Goetz LJ, Hayward SW, Sadar MD, Gilks CB, Gout PW, Squire JA, Cunha GR, Wang YZ. Wang Y, et al. Among authors: wang yz. Lab Invest. 2005 Nov;85(11):1392-404. doi: 10.1038/labinvest.3700335. Lab Invest. 2005. PMID: 16155594 Free article.

4

Establishment in severe combined immunodeficiency mice of subrenal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: potential models for studying tumor progression-related changes.

Cutz JC, Guan J, Bayani J, Yoshimoto M, Xue H, Sutcliffe M, English J, Flint J, LeRiche J, Yee J, Squire JA, Gout PW, Lam S, Wang YZ. Cutz JC, et al. Clin Cancer Res. 2006 Jul 1;12(13):4043-54. doi: 10.1158/1078-0432.CCR-06-0252. Clin Cancer Res. 2006. PMID: 16818704

5

Sulfasalazine-induced cystine starvation: potential use for prostate cancer therapy.

Doxsee DW, Gout PW, Kurita T, Lo M, Buckley AR, Wang Y, Xue H, Karp CM, Cutz JC, Cunha GR, Wang YZ. Doxsee DW, et al. Among authors: wang y, wang yz. Prostate. 2007 Feb 1;67(2):162-71. doi: 10.1002/pros.20508. Prostate. 2007. PMID: 17075799

6

The androgen receptor negatively regulates the expression of c-Met: implications for a novel mechanism of prostate cancer progression.

Verras M, Lee J, Xue H, Li TH, Wang Y, Sun Z. Verras M, et al. Among authors: wang y. Cancer Res. 2007 Feb 1;67(3):967-75. doi: 10.1158/0008-5472.CAN-06-3552. Cancer Res. 2007. PMID: 17283128

7

ASAP1, a gene at 8q24, is associated with prostate cancer metastasis.

Lin D, Watahiki A, Bayani J, Zhang F, Liu L, Ling V, Sadar MD, English J, Fazli L, So A, Gout PW, Gleave M, Squire JA, Wang YZ. Lin D, et al. Cancer Res. 2008 Jun 1;68(11):4352-9. doi: 10.1158/0008-5472.CAN-07-5237. Cancer Res. 2008. PMID: 18519696

8

Inhibition of the androgen receptor as a novel mechanism of taxol chemotherapy in prostate cancer.

Gan L, Chen S, Wang Y, Watahiki A, Bohrer L, Sun Z, Wang Y, Huang H. Gan L, et al. Among authors: wang y. Cancer Res. 2009 Nov 1;69(21):8386-94. doi: 10.1158/0008-5472.CAN-09-1504. Epub 2009 Oct 13. Cancer Res. 2009. PMID: 19826044 Free PMC article.

9

Development of metastatic and non-metastatic tumor lines from a patient's prostate cancer specimen-identification of a small subpopulation with metastatic potential in the primary tumor.

Lin D, Bayani J, Wang Y, Sadar MD, Yoshimoto M, Gout PW, Squire JA, Wang Y. Lin D, et al. Among authors: wang y. Prostate. 2010 Nov 1;70(15):1636-44. doi: 10.1002/pros.21199. Prostate. 2010. PMID: 20564316

10

Use of irinotecan for treatment of small cell carcinoma of the prostate.

Tung WL, Wang Y, Gout PW, Liu DM, Gleave M, Wang Y. Tung WL, et al. Among authors: wang y. Prostate. 2011 May 15;71(7):675-81. doi: 10.1002/pros.21283. Epub 2010 Oct 14. Prostate. 2011. PMID: 20949523

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

270,615 results

Search Page